Detalhe da pesquisa
1.
Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.
Mol Ther Nucleic Acids
; 4: e236, 2015 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-25872029